LAMEDITECH Co., Ltd. (KOSDAQ:462510)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,990.00
+220.00 (7.94%)
Aug 12, 2026, 3:30 PM KST

LAMEDITECH Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
6,0787,1876,5772,9182,0561,029
Revenue Growth
-19.21%9.28%125.37%41.95%99.85%403.91%
Gross Profit
2,6363,1482,357899.43284.81366.86
Operating Income
-11,734-11,844-9,662-3,526-3,344-1,881
Net Income
-11,507-11,367-9,484-8,305-4,430-1,867
Earnings Per Share
-1309.40-1298.51-1177.00-1525.00-889.00-18734.16
EPS Growth
------

Revenue by Segment

Fiscal YearFY 2024FY 2023FY 2022FY 2021
Period EndingDec '24 Dec '23 Dec '22 Dec '21
Lasers and Other Skin Care/Medical Devices
5,369---
Laser Blood Collector
1,128---
Other
80.71161.91195.6921.94
Laser Blood Collection Device - HandyRay Lite LMT-1000 (For Medical Institutions)
-929.4424.21331.5
Laser and Other Skin Care/Medical Devices - Puracell FX-5000 (For Professionals)
-616.31393.14496.15
Laser and Other Skin Care/Medical Devices - Puracell ME FX-1000 (For Home Care)
-594.172.02-
Laser Blood Collection Device - HandyRay Lite LMT-1000 (For Personal Use)
-274.9854.776.79
Laser and Other Skin Care/Medical Devices - Carebeam EX-3000 (For Humans)
-144.3711.9491.1
Laser Blood Collection Device - Blood Collection Device Consumables
-93.198.111.18
Laser and Other Skin Care/Medical Devices - Global Distributor ODM
-77.351,287-
Laser and Other Skin Care/Medical Devices - Rayvet EX-3000 (For Animals)
-18.318.58-
Laser and Other Skin Care/Medical Devices - Puracell ME Consumables
-8.28--

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
5,5798,55411,1596,0493,7295,931
Total Debt
7,4517,304932.051,4671,6641,690
Net Cash (Debt)
-1,8721,25010,2274,5832,0654,241
Net Cash Growth
--87.78%123.18%121.92%-51.31%1596.10%
Net Cash Per Share
-213.04142.771269.26841.49414.3842559.78

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-13,046-13,162-9,807-3,760-3,387-1,823
Capital Expenditures
-2,059-2,113-4,054-145.55-307.58-177.26
Free Cash Flow
-15,104-15,275-13,860-3,905-3,695-2,001
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
43.38%43.79%35.84%30.82%13.85%35.66%
Operating Margin
-193.07%-164.78%-146.90%-120.82%-162.66%-182.85%
Pretax Margin
-189.34%-158.15%-144.20%-284.58%-215.50%-181.49%
Profit Margin
-189.34%-158.15%-144.20%-284.58%-215.50%-181.50%
FCF Margin
-248.52%-212.52%-210.74%-133.82%-179.74%-194.49%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
4.018.0710.73---